Sergei Gryaznov
Directeur Technique/Scientifique/R&D chez MAIA BIOTECHNOLOGY, INC.
Fortune : 211 427 $ au 31/05/2024
Postes actifs de Sergei Gryaznov
Sociétés | Poste | Début | Fin |
---|---|---|---|
MAIA BIOTECHNOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/12/2019 | - |
Historique de carrière de Sergei Gryaznov
Anciens postes connus de Sergei Gryaznov
Sociétés | Poste | Début | Fin |
---|---|---|---|
GERON CORPORATION | Corporate Officer/Principal | 01/01/2013 | 01/01/2013 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA. | Corporate Officer/Principal | 01/01/1993 | 01/01/1997 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Sergei Gryaznov
Moscow State University Lomonosov | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Russie | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GERON CORPORATION | Health Technology |
MAIA BIOTECHNOLOGY, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA. | Health Technology |
- Bourse
- Insiders
- Sergei Gryaznov
- Expérience